findmyKOL

Chadi Hage, MD

Basic profile

University of Pittsburgh Medical Center

ORCID↗NPI↗
✓ Full record
RegionPittsburgh, PA · NortheastSpecialtyPulmonary DiseaseFocusRespiratory
Active KOLfindmyKOL type: RegionalLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH funding2024–2026

Chadi Hage is a Respiratory physician affiliated with University of Pittsburgh Medical Center. OpenAlex indexes 226 publications with 8,302 citations (h-index 49).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
226publications

Distinct works indexed by OpenAlex, matched via ORCID.

8,302citations

Total citations across indexed works.

49h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2024–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

3601 5th Avenue
4th Floor Falk, Comprehensive Lung Center
Pittsburgh, PA 152131521

Telephone

317-962-5820

Provider last certified this registry record 26 Jan 2023.

View the NPPES registry record

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    24.2%
    Short-acting sulfonamides10.2%
    Sulfamethoxazole-Trimethoprim100%
    Part D≥43 patients
    Macrolide Antimicrobial9.7%
    Azithromycin100%
    Part D≥42 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    22.4%
    Corticosteroid8.2%
    Prednisone100%
    Part D≥38 patients
    Proton pump inhibitor8.1%
    Pantoprazole Sodium89%Lansoprazole11%
    Part D<11 patients

    + 4 more classes in this area

  • Cardiovascular

    16%
    Statin6.1%
    Pravastatin Sodium59%Rosuvastatin Calcium29%Atorvastatin Calcium12%
    Part D<11 patients
    Beta blocker4.3%
    Metoprolol Tartrate72%Carvedilol28%
    Part D<11 patients

    + 3 more classes in this area

Where care is delivered (Part B)90.5% facility · 9.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”